175 related articles for article (PubMed ID: 27173253)
21. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
Zhang H; Ge J; Hong H; Bi L; Sun Z
World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
[TBL] [Abstract][Full Text] [Related]
22. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
Zhou CX; Zhao JH
Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
[TBL] [Abstract][Full Text] [Related]
23. Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population.
Zhao R; Ying MF
Genet Mol Res; 2016 Mar; 15(1):15017263. PubMed ID: 26985954
[TBL] [Abstract][Full Text] [Related]
24. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
Qian T; Zhang B; Qian C; He Y; Li Y
Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298
[TBL] [Abstract][Full Text] [Related]
25. Role of single nucleotide polymorphisms of DNA repair genes in susceptibility to pancreatic cancer in Chinese population.
Ying MF; Zhao R
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050953
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Valdivia-Bautista J; Faus-Dáder MJ; Calleja-Hernández MÁ
Pharmacogenomics J; 2019 Apr; 19(2):164-177. PubMed ID: 29662106
[TBL] [Abstract][Full Text] [Related]
27. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors.
Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H
Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164
[TBL] [Abstract][Full Text] [Related]
28. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis.
Zhao H; Wang LE; Li D; Chamberlain RM; Sturgis EM; Wei Q
Carcinogenesis; 2008 Aug; 29(8):1560-6. PubMed ID: 18635523
[TBL] [Abstract][Full Text] [Related]
29. Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer.
Liu L; Li CH; Jin TF; Xu DY
Genet Mol Res; 2014 Oct; 13(4):8722-8. PubMed ID: 25366763
[TBL] [Abstract][Full Text] [Related]
30. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
[TBL] [Abstract][Full Text] [Related]
31. ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.
Yin M; Yan J; Martinez-Balibrea E; Graziano F; Lenz HJ; Kim HJ; Robert J; Im SA; Wang WS; Etienne-Grimaldi MC; Wei Q
Clin Cancer Res; 2011 Mar; 17(6):1632-40. PubMed ID: 21278243
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer.
Tang Y; Zhang R; Li Y; Xu S; Wang H; Xu J; Xiao L; Wang Y; Du J; Huang Y; Su T
BMC Cancer; 2021 Jul; 21(1):842. PubMed ID: 34284736
[TBL] [Abstract][Full Text] [Related]
33. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population.
Chu H; Gu D; Xu M; Xu Z; Gong Y; Gong W; Tang Y; Zhou J; Tong N; Zhang Z; Chen J; Wang M
Mutagenesis; 2013 Jul; 28(4):441-6. PubMed ID: 23680703
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung.
Lee MS; Liu CY; Su L; Christiani DC
Lung Cancer; 2015 Jul; 89(1):8-12. PubMed ID: 26001533
[TBL] [Abstract][Full Text] [Related]
35. Association of NER pathway gene polymorphisms with susceptibility to laryngeal cancer in a Chinese population.
Sun Y; Tan L; Li H; Qin X; Liu J
Int J Clin Exp Pathol; 2015; 8(9):11615-21. PubMed ID: 26617899
[TBL] [Abstract][Full Text] [Related]
36. Genetic variability of DNA repair mechanisms influences treatment outcome of gastric cancer.
Ding C; Zhang H; Chen K; Zhao C; Gao J
Oncol Lett; 2015 Oct; 10(4):1997-2002. PubMed ID: 26622786
[TBL] [Abstract][Full Text] [Related]
37. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
38. Study of association between pre-senile cataracts and rs11615 of ERCC1, rs13181 of ERCC2, and rs25487 of XRCC1 polymorphisms in a Spanish population.
López-Valverde G; Garcia-Martin E; Fernández-Mateos J; Cruz-González F; Larrosa-Povés JM; Polo-Llorens V; Pablo-Júlvez LE; González-Sarmiento R
Ophthalmic Genet; 2017; 38(4):314-319. PubMed ID: 27668351
[TBL] [Abstract][Full Text] [Related]
39. Association of ERCC gene polymorphism with osteosarcoma risk.
Wang G; Li J; Xu X; Gupta RK; Gao X
Afr Health Sci; 2020 Dec; 20(4):1840-1848. PubMed ID: 34394247
[TBL] [Abstract][Full Text] [Related]
40. Frequency distribution of DNA repair genes ERCC1 and ERCC2 polymorphisms in South Indian healthy population.
Rao KS; SureshKumar S; Umamaheswaran G; Paul A; Dubashi B; Gunaseelan K; Dkhar SA
Environ Toxicol Pharmacol; 2014 Sep; 38(2):480-8. PubMed ID: 25155628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]